FReSH-83199-en
Impact of Combined Neoadjuvant Chemotherapy on the Complete Pathological Response Rate in Triple-Negative Breast Cancer
ICNCP
| Name | Country code |
|---|---|
| France | fr |
This study explores the efficacy of a neoadjuvant chemotherapy regimen in patients with locally advanced triple-negative breast cancer. The primary objective is to determine the rate of pathological complete response after treatment, as well as to evaluate tolerability and associated side effects. Patients are followed for a period of 24 months to also analyze recurrence-free survival and overall survival, with particular attention paid to biomarkers predictive of treatment response.
['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Anthropometry','Paraclinical data (non-biological) : Function testing','Other']
Individus
| Topic | Vocabulary |
|---|---|
| Healthcare system determinants | health determinant |
| Healthcare system determinants: Access to care | health determinant |
| Healthcare system determinants: Quality of care | health determinant |
| Behavioral determinants | health determinant |
| Behavioral determinants: Eating habits | health determinant |
| Behavioral determinants: Hygiene | health determinant |
| Other | health determinant |
| Other factors, details | other determinant |
['Ile-de-France','Mayotte','Provence - Alpes - Côte d'Azur']
{
"level_sex_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D005260"
},
"value": "Female"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008297"
},
"value": "Male"
}
],
"level_age_clusion_I": [
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D055815"
},
"value": "Young Adult (19 to 24 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000328"
},
"value": "Adult (25 to 44 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D008875"
},
"value": "Middle Aged (45 to 64 years)"
},
{
"concept": {
"vocab": "MeSH",
"vocabURI": "D000368"
},
"value": "Aged (65 to 79 years)"
}
],
"level_type_clusion_I": "General population",
"level_type_clusion_other": "",
"clusion_I": "",
"clusion_E": ""
}
| Name |
|---|
| Tohmas;Martin |
| Name | Role |
|---|---|
| AGENCE DE L ENVIRONNEMENT ET DE LA MAITRISE DE L ENERGIE (ADEME) | sponsor |
| Name |
|---|
| AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE) |
| Name |
|---|
| Pharm ;10 |
| ABBVIE |
| Agency name |
|---|
| ANSM |
| CNIL |
['Administrative database (employees, pupils, students, etc.)','Disease and death registry','Other']
['{"concept":{"vocab":"CESSDA","vocabURI":"Probability"},"value":"Probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability"},"value":"Non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}']
Observational Study
| Start | End |
|---|---|
| 2026-09-08 | 3000-01-01 |
Collection Frequency *
| Name | |
|---|---|
| Thomas;MARTIN | med8@impact-dev.tn |
{"extLink":{"title":"COAR","uri":"http://purl.org/coar/access_right/c_abf2"},"value":"Open access"}
| Name | |
|---|---|
| Thomas;MARTIN | med8@impact-dev.tn |
| Pharm ;10 | pharm10@impact-dev.tn |
FReSH-83199-en
| Name |
|---|
| Tohmas Martin |